Comment on FDA asthma-drug ruling affects Cornerstone

FDA asthma-drug ruling affects Cornerstone

The U.S. Food and Drug Administration is now asking that makers of asthma drugs in a specific class of medications include a precaution in the labeling explaining that neuropsychiatric events have been reported in some patients taking these products – a ruling that affects Cary-based Cornerstone Therapeutics.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News